Overview
rs11226 is a genetic variant on gene RAD52.
This variant is located on chromosome 12. The variations at position 912647 are the genetic letters A/A, G/G, A/G
Since humans have each twice (one from each parent), these letter-variations occur on both chromosomes. People can have the same or different letters on both chromosomes. Every person's individual variation combination is referred to as genotype. For variant rs11226 there are 3 currently known genotypes : A/A, G/G or A/G
Short Overview
Variant Location
rs11226 is located on gene RAD52 in chromsome 12. Use the genome browser to explore the location of rs11226 and its genetic neighbourhood.
Conditions & Traits
rs11226 affects the following conditions and traits:
There are currently 0 conditions and 0 traits associated with rs11226.
Pathogenicity
rs11226 affects the following conditions:
There are currently 0 conditions associated with rs11226.
Genome Browser
This interactive browser visualizes what no human can see with the naked eye - our DNA. From a down to a specific position on a . The position you are looking at here is the exact location of variant rs on gene RAD52. Explore more variants and their effects on the body by browsing left and right along the DNA strand.
Did you know genetic variants affect drugs?
Mutations are changes in genes and genetic variations are differences in the DNA among people. Variants are tiny changes in just one piece of the DNA while haplotypes are groups of these changes that usually come together.
Conditions & Traits of rs11226
Current research shows 0 conditions and 0 traits.
Conditions
0Pharmacogenetics
The genetic variant rs11226 impacts how certain medications work in the body. This difference may cause some of us to require different dosage amounts to achieve the desired effects, while others might experience more apparent side-effects. As a result, healthcare providers may need to adjust prescriptions for those individuals with rs11226. Ultimately, understanding our genetic makeup helps improve the overall effectiveness and usability of medications. Tailoring treatments based on genetics ensures a safer, more personalized healthcare experience.
Genotype
Level of evidence
Impacts
Summary
Breakdown
Drug Effect
Side Effects
Dosage
No summary available.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype A/G have decreased Side Effects to CISPLATIN.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have increased Side Effects to CISPLATIN.
more info
Legend:
Increased
Decreased
No known effect
Genotype
Level of evidence
Impacts
Summary
Breakdown
Drug Effect
Side Effects
Dosage
No summary available.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype A/G have decreased Side Effects to CYCLOPHOSPHAMIDE.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have increased Side Effects to CYCLOPHOSPHAMIDE.
more info
Legend:
Increased
Decreased
No known effect
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
No summary available.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype A/G have decreased Side Effects to CISPLATIN.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype G/G have increased Side Effects to CISPLATIN.
Level of evidence
More info
Legend:
Increased
Decreased
No known effect
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
No summary available.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype A/G have decreased Side Effects to CYCLOPHOSPHAMIDE.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype G/G have increased Side Effects to CYCLOPHOSPHAMIDE.
Level of evidence
More info
Legend:
Increased
Decreased
No known effect
Drugs related to rs11226
All drugs that are linked to rs11226 are listed here.
Studies and Sources
All of the resources below examine variant rs11226
Joellen M Schildkraut, Edwin S Iversen, Melanie A Wilson, Merlise A Clyde, Patricia G Moorman, Rachel T Palmieri, Regina Whitaker, Rex C Bentley, Jeffrey R Marks, Andrew Berchuck
Hui-Chen Wu, Lissette Delgado-Cruzata, Nicola Machella, Qiao Wang, Regina M Santella, Mary Beth Terry
Alessio Naccarati, Fabio Rosa, Veronika Vymetalkova, Elisa Barone, Katerina Jiraskova, Cornelia Di Gaetano, Jan Novotny, Miroslav Levy, Ludmila Vodickova, Federica Gemignani, Tomas Buchler, Stefano Landi, Pavel Vodicka, Barbara Pardini